|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.86 CAD | +2.45% |
|
+2.45% | +12.91% |
| 07-11 | Knight Therapeutics Announced Normal Course Issuer Bid | MT |
| 07-11 | Knight Therapeutics Brief: Announcing Normal Course Issuer Bid | MT |
Knight Therapeutics Inc. (TSX:GUD) announces a share repurchase program. Under the normal course issuer bid, the company will repurchase up to 5,312,846 shares, representing 5.24% of its issued and outstanding share capital. The repurchased shares will be cancelled.
The bid will expire on the earlier of the date on which purchases under the bid have been completed and July 14, 2025. As of June 30, 2024, the company had 101,327,297 common shares issued and outstanding.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.91% | 435M | |
| +5.24% | 72.01B | |
| +30.80% | 10.39B | |
| +41.28% | 5.26B | |
| -18.53% | 4.64B | |
| +18.24% | 3.7B | |
| +26.86% | 2.3B | |
| -39.52% | 1.8B | |
| -45.54% | 1.7B | |
| -0.50% | 1.64B |
KNIGHT THERAPEUTICS INC. 
